4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-20-017240
Executive VP, Head of R&D gave up 1,563 shares (to pay taxes)
- Executive VP, Head of R&D acquired 3,333 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Tony W Executive VP, Head of R&D | 2020-03-05 | Option exercise | +3,333 | 49,168 | D | ||
| Ho Tony W Executive VP, Head of R&D | 2020-03-06 | Shares withheld for taxes | −1,563 | $52.64 | $82,276 | 47,605 | D |
Loading xslF345X03/doc4.xml…